Overcoming Resistance to Immune Checkpoint Inhibitor Therapy Using Calreticulin-Inducing NanoparticleSri Vidhya Chandrasekar(Oklahoma State University), Ashish Ranjan(Oklahoma State University)PharmaceuticsJune 9, 202310.3390/pharmaceutics15061693Cited by 5SaveCiteExport RISWatch citationsRelated PapersChemo-immunotherapy of colon cancer with focused ultrasound and Salmonella-laden temperature sensitive liposomes (thermobots)|Scientific Reports|2018|98Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity|Theranostics|2020|69